Souhaitez-vous accéder aux communiqués récents ?

Telix Pharmaceuticals reported strong Q1 2025 revenue of $186 million, up 62% year-on-year, driven by Illuccix® sales and RLS Radiopharmacies acquisition.

FORESIGHT VCT PLCLEI: 213800GNTY699WHACF4616 April 2025 Final results31 December 2024 Foresight VCT plc, managed by Foresight Group LLP, today announces the final results for the year ended 31...

Wilmington, Delaware, April 15, 2025 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Hospital and Pre-hospital External Defibrillator Market - Global Opportunity Analysis and...

TORONTO, April 15, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of the Vector Institute is pleased to announce the appointment of Glenda Crisp as President & CEO effective April 21, 2025. ...

The Lachine Hospital Foundation’s signature Gala raised an incredible $406,500 to support the Dream Big: Lachine Hospital campaign, a successful collaboration between the Lachine Hospital Foundation...

Toronto, Ontario, April 11, 2025 (GLOBE NEWSWIRE) -- In this federal election, your vote holds the power to change the future for seniors in Canada. Alarming statistics show that 1 in 3 seniors is...

Canada’s Vector Institute has assessed 11 leading AI models from around the world, using 16 performance benchmarks

Aprocitentan, on top of background therapy, showed clinically meaningful and durable blood pressure (BP) reduction and a decrease in proteinuria in Black patients with confirmed resistant hypertension...

CASP Conference, May 14-16, 2025 fosters diverse insights on suicide prevention and life promotion with pre-conference Healing Day on May 13, 2025.

MELBOURNE, Australia and INDIANAPOLIS, April 04, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces the appointment of Anne Whitaker...